[5] Despite presenting its product as an alternative to other medications that work to treat obesity, the advertisement obscures the fact that Hims weight loss medications are unapproved, compounded products that have not been subject to clinical testing or FDA scrutiny and pose a higher risk to patients than FDA-approved drugs. [6] Most alarmingly, the commercial makes no mention of side-effects, warnings, or the potentially serious risks posed by any semaglutide product
Quick Answer Reconstituted retatrutide, stored at 36-46F (2-8C), is generally stable for 28 to 60 days based on general bacteriostatic water peptide compounding principles
Data analysed by one-way ANOVA, multiple comparison, Bonferroni post hoc test ( a - c and g - k ) and two-way repeated measures ANOVA to assess main effects of treatment ( e and f )
Retatrutide is discussed in research settings as LY 3437943 and is commonly described as acting across multiple peptide receptor families, which is why it is frequently chosen for comparative profiling experiments